Neurology News

May is Brain Tumor Awareness Month.

Earlier this year, the FDA granted breakthrough device designation to Quanterix for its blood-based diagnostic assay to aid in the diagnosis of Alzheimer’s disease.

Novel forms of a rare genetic variant may contribute to the risk for co-occurring Parkinson’s disease and inflammatory bowel disease, according to research presented in Genome Medicine.

DENVER — Efficacy of fumarates to treat multiple sclerosis was consistent across four racial and ethnic groups, particularly for Black, Hispanic and Asian persons, according to a poster at the American Academy of Neurology annual meeting.

The number of pills containing illicit fentanyl that were seized by United States law enforcement in 2023 was 2,300 times greater than the number in 2017, according to a study published in the International Journal of Drug Policy.

AC Immune SA ad Takeda have announced an exclusive, worldwide option and license agreement for the former’s active immunotherapies that target toxic forms of the biomarker amyloid beta to treat Alzheimer’s disease.

DENVER — Treatment with 10 mg zavegepant nasal spray was associated with a higher likelihood of pain freedom compared with placebo at 2 hours post dose, according to a presentation at the American Academy of Neurology annual meeting.

A phase 1 trial showed chimeric antigen receptor T-cell therapy may hold promise for the treatment of glioblastoma.

Life as a health care professional can be stressful, but there is a quick technique that can combat feelings of tension.

DENVER — A combination therapy of ciprofloxacin and celecoxib demonstrated a favorable safety profile for those with amyotrophic lateral sclerosis, Merit Cudkowicz, MD, MSc, said in this Healio video.